Lv1
10 积分 2023-07-10 加入
Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial
1天前
待确认
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
1天前
已完结
Inhibiting bridge integrator 2 phosphorylation leads to improved oocyte quality, ovarian health and fertility in aging and after chemotherapy in mice
5个月前
已完结
Discovery of 2-Pyrazolylpyrimidinone Derivatives as New SPOP Inhibitors for Renal Cell Carcinoma Therapy
10个月前
已完结
Características inmunológicas claves en la fisiopatología de la sepsis. Infectio
10个月前
已完结
Lactylation of XLF promotes non-homologous end-joining repair and chemoresistance in cancer
11个月前
已完结
皖公网安备34019202002308
